clinical trial · NCT06323655
Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects
Healthy VolunteersTasimelteonActive Control PlaceboTasimelteon PlaceboActive Control
brief summary
The aim of this study is to investigate next-day residual effects of tasimelteon compared with placebo and active control in healthy subjects.
started
Jul 19, 2018
primary completion
Aug 28, 2018
completion
Aug 28, 2018
last updated
Mar 21, 2024
official title
A Randomized, Double-blind, Double-dummy, Placebo-controlled, Three-way Crossover Study in Healthy Subjects to Evaluate the Next-day Residual Effects of 20 mg Tasimelteon
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol